In this NSCLC-ALK network, since the longest follow-up time is approximately 65 months (PROFILE 1014, chemotherapy), we set “The max timepoint” to 60 and “Step of the timepoint” to 6. The gene discussed is ALK; the disease is non-small cell lung carcinoma.